Premium
GC/MS Profiling, In Vitro and In Silico Pharmacological Screening and Principal Component Analysis of Essential Oils from Three Exotic and Two Endemic Plants from Mauritius
Author(s) -
Sharmeen Jugreet Bibi,
Kouadio Ibrahime Sinan,
Zengin Gokhan,
Abdallah Hassan H.,
Fawzi Mahomoodally Mohamad
Publication year - 2021
Publication title -
chemistry and biodiversity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 70
eISSN - 1612-1880
pISSN - 1612-1872
DOI - 10.1002/cbdv.202000921
Subject(s) - chemistry , dpph , syzygium , traditional medicine , botany , antioxidant , biochemistry , biology , medicine
The chemical and pharmacological profiles of essential oils (EOs) hydrodistilled in yields of 0.03–0.77 % (w/w) from three exotic ( Cinnamomum camphora , Petroselinum crispum , and Syzygium samarangense ) and two endemic ( Pittosporum senacia subsp. senacia and Syzygium coriaceum ) medicinal plants were studied. GC‐MS/GC‐FID analysis of the EOs identified the most dominant components to be myristicin (40.3 %), myrcene (62.2 %), 1,8‐cineole (54.0 %), β‐pinene (21.3 %) and ( E ) ‐ β‐ocimene (24.4 %) in P. crispum , P. senacia and C. camphora , S. samarangense and S. coriaceum EOs, respectively. All EOs were found to possess anti‐amylase (0.70–1.50 mM ACAE/g EO) and anti‐tyrosinase (109.35–158.23 mg KAE/g) properties, whereas no glucosidase inhibition was displayed. Only Syzygium EOs acted as dual inhibitors of both acetyl‐ and butyryl‐cholinesterases, while P. senacia and C. camphora EOs inhibited acetylcholinesterase selectively and P. crispum EO was inactive (AChE: 4.64–4.96 mg GALAE/g; BChE: 5.96 and 7.10 mg GALAE/g). Molecular docking revealed 1,8‐cineole to present the best binding affinities with butyrylcholinesterase, amylase and tyrosinase, while both myristicin and β‐pinene with acetylcholinesterase and finally β‐pinene with glucosidase. In vitro antioxidant potency was also demonstrated in different assays (DPPH: 13.52–53.91 mg TE/g, ABTS: 5.49–75.62 mg TE/g; CUPRAC: 45.38–243.21 mg TE/g, FRAP: 42.49–110.64 mg TE/g; and phosphomolybdenum assay: 82.61–160.93 mM TE/g). Principal component analysis revealed the EOs to differ greatly in their bioactivities due to their chemodiversity. This study has unveiled some interesting preliminary pharmacological profiles of the EOs that could be explored for their potential applications as phytotherapeutics.